This strain carries a conditional mutant Kras (KrasLSL-G12D/WT) and a constitutive deletion of Trp53 (p53KO/KO). G12D mutant Kras was activated upon injecting adeno-cre directly to the pancreas at 6 weeks of age, which resulted in a pancreatic tumor 8 weeks later. This result is similar to previous reports with similar models, including a Pdx1-Cre; KrasLSL-G12D/WT; p53KO/KO model (http://www.ncbi.nlm.nih.gov/pubmed/24305049) and a iKras; p53loxp/loxp model (http://www.ncbi.nlm.nih.gov/pubmed/22541435).
Summary | |
---|---|
Cancer Type | Pancreatic Cancer |
Subtype | N/A |
Mutations | KRAS (G12D); P53-/- |
Biopsy Site | Pancreases |
Pathology QC | High grade spindle cell sarcoma (P0), poorly differentiated squamous cell carcinoma (P3) |
Mouse Strain | C57BL/6 |
TMA | TMA-MP-MX-001 |